Valeant Pharmaceuticals Can Still Go Higher – Cramer’s Lightning Round (5/21/18)

Stocks discussed on the Lightning Round segment of Jim Cramer’s Mad Money Program, Monday, May 21.

Bullish Calls

Royal Caribbean Cruises (NYSE:RCL): People are worried about rising raw costs and rising competition. Cramer thinks they’re wrong. It’s a buy.

Valeant Pharmaceuticals International (NYSE:VRX): “CEO Joe Papa’s doing a great job. Now, it is not going to run fast, OK? But it has had a great move, Joe is doing so much good, he’s got a good pipeline, fixing the balance sheet, got ’em out of legal trouble. I can’t tell you to take profits. I think it could still go higher.”

Walgreens Boots Alliance (NASDAQ:WBA): It’s an overly hated stock which is too low to sell. It’s a buy.

Southern Company (NYSE:SO): It’s come down a lot on interest rate worries. Cramer likes the stock along with Dominion Energy (NYSE:D).

Neutral Call

Okta (NASDAQ:OKTA): The stock has gone up 100%. It’s a good company but the stock has moved up a lot. Hold it.

Bearish Calls

Allergan (NYSE:AGN): This has been Cramer’s worst stock in a decade. Don’t buy.

Tyson Foods (NYSE:TSN): They did not have a good last quarter and the food group is a tough place to be now. Cramer does not see a catalyst.

Carrizo Oil & Gas (NASDAQ:CRZO): The company is smart and well-run. It has moved up a lot and unless oil is going to $90, it’s too late to buy in.

Crispr Therapeutics (NASDAQ:CRSP): The stock has run up 175% and Cramer could not recommend a buy this high. He also doesn’t mean to say that the ship has sailed.


Jim Cramer’s Action Alerts PLUS: Check out Cramer’s multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer’s Picks by email – it’s free and takes only a few seconds to sign up